| Structure |
Chemical Name |
CAS |
MF |
![(Z)-Methyl 3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate](/CAS/20130318/GIF/CB12611218.gif) |
(Z)-Methyl 3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-2-oxo-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate |
1499167-72-4 |
C23H20N4O4 |
 |
1-(4-((2-(4-hydroxypiperidin-1-yl)ethyl)(methyl)carbamoyl)benzyl)piperidine-4-carboxamide |
|
|
 |
アトルバスタチン環状(フルオロフェニル)ナトリウム塩不純物 |
1315629-79-8 |
C33H35FN2O7.Na |
![2-[(E)-シアノ(2,3-ジクロロフェニル)メチレン]ヒドラジンカルボイミドアミド](/CAS/GIF/94213-24-8.gif) |
2-[(E)-シアノ(2,3-ジクロロフェニル)メチレン]ヒドラジンカルボイミドアミド |
94213-24-8 |
C9H7Cl2N5 |
 |
3(S)-Hydroperoxy Simvastatin |
1092716-44-3 |
C25H38O7 |
 |
Moxifloxacin Impurity 32 |
|
|
 |
Cefazolin Impurity 2 |
|
|
 |
Palbociclib Impurity 41 |
|
|
 |
2-(4-fluorophenyl)-5-(2-Methylbenzyl)thiophene |
2005454-69-1 |
C18H15FS |
![(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate](/CAS/20180601/GIF/104873-15-6.gif) |
(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate |
104873-15-6 |
C17H18N2O7 |
 |
ibrutinib iMpurity A |
|
|
 |
DVCUGHHGLKCBMT-QVDQXJPCSA-N |
1356353-76-8 |
C15H24N6O6 |
 |
メナキノン4 2,3-エポキシド |
72908-86-2 |
C31H40O3 |
 |
Lasmiditan Impurity 9 |
|
|
 |
Dihydro-Simvastatin |
92083-03-9 |
C25H40O5 |
 |
Aristolactam IIIa N-β-glucoside |
80311-26-8 |
C22H19NO9 |
 |
(S)-Olodaterol |
868049-50-7 |
C21H26N2O5 |
 |
Tafluprost Impurity 18 |
|
|
 |
Cinacalcet Impurity 38 HCl |
938177-81-2 |
C21H24ClN |
![Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide](/CAS/20210305/GIF/2004659-83-8.gif) |
Sorafenib impurity 24/N-Methyl-4-[4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-2-pyridinecarboxamide |
2004659-83-8 |
C20H19N5O3 |
 |
Dolutegravir Impurity 4 |
|
|
 |
(3R,5R)-ロスバスタチンラクトン |
1422954-11-7 |
C22H26FN3O5S |
 |
BIRG 613 BS |
287980-85-2 |
C15H16N4O |
 |
Nicardipine Related CoMpound 2 |
64603-72-1 |
C16H14N2O6 |
 |
Linagliptin Impurity 26 |
2446799-71-7 |
C20H17BrN6O2 |
 |
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo- |
2410658-30-7 |
C15H14FNO5 |
 |
Oseltamivir Impurity 59 |
2485836-60-8 |
C12H22N2O3 |
 |
Tacrolimus Impurity F |
|
|
 |
Pyridine, 4-chloro-2-(chloromethyl)-3,5-dimethyl-, hydrochloride |
143016-68-6 |
C8H10Cl3N |
![(3R,4R,5R)-3-(1-エチルプロポキシ)-4-ヒドロキシ-5-[(メチルスルホニル)オキシ]-1-シクロヘキセン-1-カルボン酸エチルエステル](/CAS/GIF/204254-92-2.gif) |
(3R,4R,5R)-3-(1-エチルプロポキシ)-4-ヒドロキシ-5-[(メチルスルホニル)オキシ]-1-シクロヘキセン-1-カルボン酸エチルエステル |
204254-92-2 |
C15H26O7S |
 |
For the determination of
impurities in Propylene |
|
|
 |
FG-4592 intermediate 8 |
1509958-20-6 |
C20H17NO6 |
 |
Tazobactam Impurity 14 |
|
|
 |
Acetamide, N-(4-hydroxyphenyl)-N-nitroso- |
146897-60-1 |
C8H8N2O3 |
 |
Febuxostat IMpurity (2-(3-carboxy-4-isobutyloxyphenyl)-4-Methylthiazole-5-carboxylic acid) |
|
|
 |
Olopatadine Impurity 4 |
55690-15-8 |
C18H18O5 |
 |
Nintedanib Impurity 52 |
2410284-89-6 |
C22H30N6O2 |
 |
Baloxavir Impurity ABCDEFGHJKL |
|
|
 |
2-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide |
2304623-37-6 |
C16H14N2O3S |
 |
Methyl 4-(4-fluorophenyl)-6-isopropyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate |
488798-36-3 |
C15H17FN2O3 |
 |
Palbociclib Impurity 91 |
571191-15-6 |
C22H27N7O2 |
 |
Rivaroxaban Impurity 76 |
|
|
 |
Tretinoin-d6 (Retinoic Acid-d6, Isotretinoin EP Impurity A-d6) |
|
|
 |
Rotigotine Impurity 7 |
|
|
 |
(3S,5R)-Atorvastatin |
887324-52-9 |
C33H35FN2O5 |
 |
1-(カルボキシメチル)シクロヘキサン-1-カルボン酸 |
67950-95-2 |
C9H14O4 |
 |
Bosutinib Impurity 7 |
|
|
 |
Oxytocin Impurity 8 Trifluoroacetate |
|
|
 |
Imatinib Impurity 3 |
|
|
 |
Sugammadex sodium Impurity 52 |
|
|
 |
Apalutamide Desfluoro Impurity |
1332389-57-7 |
C21H16F3N5O2S |
 |
Pitavastatin Impurity 19 Sodium Salt |
1980814-87-6 |
C25H24FNO5 |
 |
Empagliflozin Impurity KHC |
|
|
![(1R,2S,5S)-2-アジド-5-[(ジメチルアミノ)カルボニル]シクロヘキシルカルバミン酸=tert-ブチル](/CAS/20180906/GIF/480450-69-9.gif) |
(1R,2S,5S)-2-アジド-5-[(ジメチルアミノ)カルボニル]シクロヘキシルカルバミン酸=tert-ブチル |
480450-69-9 |
C14H25N5O3 |
![5-(5-Chlorosulfonyl-2-ethoxyphenyl)-3-propyl-1,6-dihydro_x000b_-7H-pyrazolo[4,3-d]pyrimidin-7-one](/CAS/GIF/139756-31-3.gif) |
5-(5-Chlorosulfonyl-2-ethoxyphenyl)-3-propyl-1,6-dihydro_x000b_-7H-pyrazolo[4,3-d]pyrimidin-7-one |
139756-31-3 |
C16H17ClN4O4S |
 |
Venlafaxine N-Dimer |
1187545-61-4 |
C32H48N2O4 |
 |
Pitavastatin Impurity 45 |
1258947-29-3 |
C29H32FNO4 |
 |
4,9-diisobutyl-1,6-diazecane-2,7-dione |
1990538-03-8 |
C16H30N2O2 |
 |
LUMAT-004 |
313544-31-9 |
C16H17N3O3 |
![[1,1'-ビフェニル]-2,2'-ジカルボニトリル](/CAS/GIF/4341-02-0.gif) |
[1,1'-ビフェニル]-2,2'-ジカルボニトリル |
4341-02-0 |
C14H8N2 |
 |
Vildagliptin Impurity 9 |
|
|
 |
HYDROXYMETHYL CELECOXIB |
170571-00-3 |
C17H14F3N3O3S |
 |
Sacubitril Impurity 7 |
149709-44-4 |
C22H25NO5 |
 |
Cyclopropanamine, 2-(3-fluorophenyl)-, (1R,2S)- (9CI) |
220353-83-3 |
C9H10FN |
 |
2-aMino-4-Methoxy-5-(3-Morpholinopropoxy)benzaMide |
246512-44-7 |
C15H23N3O4 |
 |
SofosBuvir Impurity 64 |
|
|
 |
Macitentan IMpurity |
556796-88-4 |
C17H15Br2N5O4S |
 |
Sugammadex Impurity 12 Monomer(Org198958-2(RRT0.45)) |
2412953-11-6 |
C72H112O49S8 |
 |
Lenvatinib Impurity 26 |
|
|
 |
Ciclosporin impurity |
2715287-08-2 |
|
 |
Crisaborole Impurity 9 |
|
|
![BenzeneMethanaMine, 4-ethoxy-3-Methoxy-a-[(Methylsulfonyl)Methyl]-](/CAS/20150408/GIF/885268-06-4.gif) |
BenzeneMethanaMine, 4-ethoxy-3-Methoxy-a-[(Methylsulfonyl)Methyl]- |
885268-06-4 |
C12H19NO4S |
![2-[4-[(1E)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine](/CAS/20150408/GIF/97151-10-5.gif) |
2-[4-[(1E)-1,2-Diphenylethenyl]phenoxy]-N,N-dimethylethanamine |
97151-10-5 |
C24H25NO |
 |
Sitagliptin IMpurity 4 |
|
|
 |
Miglitol Isomer ImpurityB |
|
|
 |
2-(2-ヒドロキシフェニル)-4-メチルチアゾール-5-カルボン酸エチル |
118485-48-6 |
C13H13NO3S |
 |
N-nitroso-desmethyl-Clemastine |
|
|
 |
Cefazolin Impurity 5 |
|
|
 |
Gabapentin EP Impurity G |
1500558-49-5 |
C10H19NO2 |
 |
Desloratadine Impurity |
50603-12-8 |
C20H21N |
 |
Cefazolin Impurity EP-J |
|
|
 |
Tafluprost Impurity 1 (Tafluprost (1S,2S,3S,5R)-Isomer) |
|
|
 |
Ropivacaine N-Oxide |
1391053-59-0 |
C17H26N2O2 |
![(3R,5S)-5-((R)-8-fluoro-4-isopropyl-2-(N-methylmethylsulfonam ido)-5,6-dihydrobenzo[h]quinazolin-6-yl)-3,5-dihydroxypentanoate calcium(II)](/CAS/20200119/GIF/854898-49-0.gif) |
(3R,5S)-5-((R)-8-fluoro-4-isopropyl-2-(N-methylmethylsulfonam ido)-5,6-dihydrobenzo[h]quinazolin-6-yl)-3,5-dihydroxypentanoate calcium(II) |
854898-49-0 |
C44H54CaF2N6O12S2 |
![(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole compound with 6-methoxy-1-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole (1:1)](/) |
(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole compound with 6-methoxy-1-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole (1:1) |
|
|
 |
Valsartan Impurity 13 |
|
C24H29N5O3 |
 |
Formoterol Impurity 13 |
150513-24-9 |
C18H24N2O3 |
 |
(1S,2R,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acid |
|
|
 |
Ezetimibe Impurity 33 |
|
|
 |
N-(2-Amino-4,5,6,7-tetrahydro-benzothiazol-6-yl)-acrylamide |
|
|
 |
Olprinone Impurity 3 |
1402751-73-8 |
C14H11N3O3 |
 |
Melphalan IMpurity |
|
|
![Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate](/CAS/20180703/GIF/1038924-97-8.gif) |
Ethyl (2R,4S)-4-([1,1'-biphenyl]-4-ylmethyl)-2-methyl-4-(2,5-dioxopyrrolidin-1-yl)butanoate |
1038924-97-8 |
C24H27NO4 |
 |
Dyclonine Impurity 2 |
66536-15-0 |
C13H16O2 |
 |
1,1,4,4-テトラフェニル-L-トレイトール |
117780-08-2 |
C28H26O4 |
 |
Dinitrogen oxide-15N |
20509-24-4 |
N15NO |
 |
R-afatinib |
945553-91-3 |
C24H25ClFN5O3 |
 |
3-メトキシ-2,4,5-トリフルオロベンゾイルクロリド |
112811-66-2 |
C8H4ClF3O2 |
 |
D-Phenylalanyl Nateglinide |
944746-48-9 |
C28H36N2O4 |
 |
Olodaterol Impurity 19 |
|
|